Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)

Nuvectis Pharma has reported Prepaid Assets for 6 years, with the latest figure at $268000.0 in Q1 2026.

• Quarterly Prepaid Assets fell 5.63% year-over-year to $268000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268000.0 (down 5.63% YoY) and the FY2025 annual result came in at $75000.0, up 1.35% from the prior year.
• Prepaid Assets improved to $268000.0 in Q1 2026 per NVCT's latest filing, from $75000.0 in the prior quarter.
• Over five years, Prepaid Assets peaked at $1.2 million in Q3 2022 and troughed at $59000.0 in Q4 2023.
• A 5-year average of $364823.5 and a median of $250000.0 in 2024 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 352.75% in 2022, then tumbled 85.68% in 2023.
• Over 5 years, Prepaid Assets stood at $412000.0 in 2022, then sank by 85.68% to $59000.0 in 2023, then gained by 25.42% to $74000.0 in 2024, then increased by 1.35% to $75000.0 in 2025, then soared by 257.33% to $268000.0 in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $268000.0, $75000.0, and $145000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.